This week on The Pulse, we are diagnosing Alzheimers with a tablespoon of peanut butter and a ruler, using urine to test for eye disease, and taking a look at how the government shutdown is inflicting long-term damage on American biomedicine. This episode features:
- The world’s first artificial larynx has been implanted, enabling the patient to regain the ability to breathe normally through the upper respiratory tract.
- By testing a patient’s ability to smell, researchers are now able to confirm diagnosis of early cases of the disease using a dollop of peanut butter and a ruler. But why peanut butter?
- Separating itself from others on the market, a nanotech sensor start-up, Adamant Technologies, is working to develop a chemical sensor that works like the human nose.
- A new Duke University study says it can link what is in a patient's urine, to gene mutations that cause retinitis pigmentosa, or RP.
- Talk of the government shutdown has been ubiquitous. But how is it affecting the medical industry?